- Controversies surrounding type III radical abdominal hysterectomy and its procedure using new instruments
-
Ushijima K, Takemoto S, Kawano K, Nishio S, Terada A, Tsuda N, Sonoda G, Ota SI, Kamura T
- KMID: 1992617
- Korean J Obstet Gynecol.
- 2012 Apr;55(4):225-229.
- doi: 10.5468/KJOG.2012.55.4.225
Type III radical abdominal hysterectomy (RAH) is standard care for early stage cervical cancer. For the past few decades, there has been a remarkable shift from surgery to radiation, in... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
-
Tsuda N, Ushijima K, Kawano K, Takemoto S, Nishio S, Sonoda G, Kamura T
- KMID: 2130104
- J Gynecol Oncol.
- 2014 Jul;25(3):229-235.
- doi: 10.3802/jgo.2014.25.3.229
OBJECTIVE: A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy in gynecologic cancers. We assessed whether the electrothermal bipolar vessel sealing device (EBVSD) could... -
- CITED
-
- Close
- SHARE
-
- Close
- Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
-
Ushijima K, Kawano K, Tsuda N, Nishio S, Terada A, Kato H, Tasaki K, Matsukuma
- KMID: 2148929
- Obstet Gynecol Sci.
- 2015 May;58(3):183-187.
- doi: 10.5468/ogs.2015.58.3.183
Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
-
Kawano K, Tsuda N, Nishio S, Yonemoto K, Tasaki K, Tasaki R, Ushijima K
- KMID: 2374255
- J Gynecol Oncol.
- 2016 Sep;27(5):e54.
- doi: 10.3802/jgo.2016.27.e54
OBJECTIVE: To identify key factors for predicting positive cone margin and appropriate cone length. METHODS: We retrospectively reviewed the margin status of patients who received conization with high grade cervical intraepithelial... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
-
Ushijima K, Fujiyoshi , Kawano K, Tsuda N, Nishio S, Eto H, Kamura T
- KMID: 2288540
- J Gynecol Oncol.
- 2013 Apr;24(2):108-113.
- doi: 10.3802/jgo.2013.24.2.108
OBJECTIVE: To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer. METHODS: Fifty-one patients with locally advanced cervical cancer (FIGO stage IB2, bulky IIA, IIB-IVA)... -
- CITED
-
- Close
- SHARE
-
- Close
